Target intelligence / Profile preview

Penicillin-binding protein 1; Penicillin-binding protein 3 (PBP1; PBP3)

Target
PBP1; PBP3
Molecular classification
Enzyme, Transpeptidase, Cell wall biosynthesis protein
01

Overview

Penicillin-binding proteins are a family of enzymes central to the synthesis and remodeling of bacterial cell walls. They catalyze the transpeptidation reaction that cross-links peptidoglycan polymers, conferring mechanical strength and shape to bacteria. These proteins are the molecular targets of β-lactam antibiotics (such as penicillins and cephalosporins), which covalently bind to their active site serine, inhibiting their enzymatic activity and thus preventing cell wall formation. PBP1 is often a bifunctional enzyme with transglycosylase and transpeptidase domains, while PBP3 is primarily a transpeptidase, both crucial for cell division and morphogenesis. Alterations in PBPs are a common mechanism of antibiotic resistance in clinically important bacteria.

Other names
PBPsClass A Penicillin-binding protein (for PBP1)Class B Penicillin-binding protein (for PBP3)TranspeptidasesPenicillin-binding proteins
02

Mechanism of action

Covalent binding of β-lactam ring of antibiotics to the active site serine of PBPs results in enzyme inactivation and blockade of peptidoglycan cross-linking, leading to cell death. Inhibition of transpeptidase activity halts cell wall synthesis, weakening the bacterium and causing lysis.

03

Biological functions

Peptidoglycan biosynthesis (catalyzes cross-linking of cell wall peptides)Cell division and morphogenesisAntibiotic target (site of β-lactam antibiotic inhibition)
04

Disease associations

Infection (bacterial pathogenicity: PBPs are required for bacterial cell wall integrity, so they are implicated in infectious disease)Antibiotic resistance (changes in PBPs can confer resistance to β-lactams)
05

Safety considerations

Resistance: Bacteria can develop resistance via mutations or acquisition of altered PBPs with decreased affinity for antibioticsOff-target toxicity is generally not a concern (PBPs are not present in humans), but drug side effects of β-lactams can arise from hypersensitivity or microbiome changes (not from PBPs themselves).
06

Interacting drugs

β-lactam antibiotics, including penicillins, cephalosporins, carbapenems, monobactams

3 more in the full profile.

07

Biomarkers

Changes in PBP sequence (mutations or expression levels) can serve as biomarkers for β-lactam resistance, especially in clinical microbiology (though specific clinical biomarkers are not routinely used)

Beyond the preview

Go deeper on Penicillin-binding protein 1; Penicillin-binding protein 3 (PBP1; PBP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Penicillin-binding protein 1; Penicillin-binding protein 3 (PBP1; PBP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call